Ceva Santé Animale (Ceva) is a global veterinary health company focused on the research, development, production, and marketing of pharmaceutical products and vaccines for companion animals (dogs, cats), poultry, ruminants (cattle, sheep, goats), and swine. The company is committed to advancing animal health and welfare worldwide, offering innovative solutions to prevent and treat diseases, and improve productivity.
Global strategic leadership, corporate finance, human resources, oversight of research and development, and manufacturing of key veterinary products and vaccines.
Modern campus integrating advanced R&D laboratories, biosecure vaccine and pharmaceutical production units, and global administrative offices. The site often highlights its commitment to biopharmaceutical innovation.
Collaborative, science-driven, and entrepreneurial, with a strong international workforce focused on innovation in animal health and welfare. Emphasis on teamwork and achieving 'Together, beyond animal health'.
Serves as the global nerve center for strategic decisions, R&D direction, and key manufacturing operations. It symbolizes Ceva's French roots and its position in the Aquitaine life sciences ecosystem, contributing significantly to the local economy.
Ceva Santé Animale operates in over 110 countries worldwide, either directly or through a network of distributors. The company supports its global functions through 17 R&D centers, 27 production sites, and numerous commercial subsidiaries across Europe, North America, Latin America, Africa, the Middle East, and Asia-Pacific. This extensive network enables Ceva to address local animal health needs while leveraging global expertise in research, manufacturing, and marketing of veterinary pharmaceuticals and vaccines.
10 avenue de la Ballastière
Libourne
Nouvelle-Aquitaine
France
Address: 8901 Rosehill Road, Lenexa, KS 66215, USA
Serves as the primary hub for Ceva's activities in the significant North American animal health market, ensuring product availability and support for veterinarians and producers.
Address: Campus de Belle-Beille, 7 rue Olivier de Serres, CS 60022, 49071 Beaucouzé Cedex, France
Key global center for vaccine R&D and production, supplying Ceva's worldwide network and supporting its leadership in preventive animal health solutions.
Address: Sumitomo Fudosan Hanzomon Ekimae Bldg. 8F, 1-10 Kojimachi, Chiyoda-ku, Tokyo 102-0083, Japan
Strategic presence in the advanced Japanese animal health market, focusing on companion animals and livestock sectors with tailored solutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, CEVA SANTE ANIMALE' leadership includes:
CEVA SANTE ANIMALE has been backed by several prominent investors over the years, including:
Ceva Santé Animale has seen some key leadership appointments and transitions in its global operations teams over the past year, reflecting its dynamic growth and strategic focus.
Discover the tools CEVA SANTE ANIMALE uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ceva Santé Animale commonly uses the 'firstname.lastname' email format. Variations might exist for common names or specific departments.
firstname.lastname@ceva.com
Format
marc.prikazsky@ceva.com
Example
90%
Success rate
Ceva Santé Animale Press Release • May 16, 2024
Ceva announced the launch of Cevac IBras®, its new live attenuated vaccine against the IBV variant strain, IBras, in Europe. This marks a significant step in protecting poultry flocks from Infectious Bronchitis....more
Ceva Santé Animale Press Release • March 12, 2024
Ceva Santé Animale announced a turnover of €1.53 billion in 2023, representing like-for-like growth of +5.7% (+3.5% at constant scope and exchange rates). The company highlighted its ongoing investments in innovation and sustainability....more
Ceva Santé Animale Press Release • January 23, 2023
Ceva announced a new shareholding structure, welcoming a consortium of new investors led by Téthys Invest SAS and Public Sector Pension Investment Board (PSP Investments), alongside existing shareholders including Ceva’s management and employees (majority shareholders) and Creadev. This strengthens Ceva’s long-term development strategy....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including CEVA SANTE ANIMALE, are just a search away.